
China is taking another step to consolidate its coal industry with plans to merge three firms that could form the country’s third-biggest miner, reported Bloomberg.
Shanxi province, the No. 2 coal producing region, is preparing to restructure three of its state-owned firms, according to people familiar with the matter.
According to Bloomberg, the merger would underscore China’s efforts to consolidate its coal industry to concentrate production in the hands of larger, more efficient firms to streamline the business. Despite global efforts to stem use of the most polluting fuel, its abundance and low cost in China have put it on course to dominate its power sector for years to come.
In the latest possible restructuring, Lu’An Mining Industry Group’s newly established chemical unit has been picked as one of the entities that could receive assets from Yangquan Coal Industry Group and Shanxi Jincheng Anthracite Mining Group, said the people, who asked not to be identified because the information isn’t public.
No final decision has been made and details of the merger are still in the works, said the people. The news was first reported by China’s Energy Magazine.
Full Content: Bloomberg
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
Judge Orders Apple to Address Fortnite App Block or Face Court Hearing
May 19, 2025 by
CPI
EU Civil Society Groups and Labor Unions Raise Alarm Over Proposed Changes to GDPR
May 19, 2025 by
CPI
EU Antitrust Regulators Push Back Deadline on UniCredit’s Takeover Bid for Banco BPM
May 19, 2025 by
CPI
Intel Challenges €376 Million EU Fine in Ongoing Antitrust Dispute
May 19, 2025 by
CPI
Red Bull Challenges EU Commission Over Lengthy Antitrust Inspection
May 19, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Healthcare Antitrust
May 14, 2025 by
CPI
Healthcare & Antitrust: What to Expect in the New Trump Administration
May 14, 2025 by
Nana Wilberforce, John W O'Toole & Sarah Pugh
Patent Gaming and Disparagement: Commission Fines Teva For Improperly Protecting Its Blockbuster Medicine
May 14, 2025 by
Blaž Višnar, Boris Andrejaš, Apostolos Baltzopoulos, Rieke Kaup, Laura Nistor & Gianluca Vassallo
Strategic Alliances in the Pharma Sector: An EU Competition Law Perspective
May 14, 2025 by
Christian Ritz & Benedikt Weiss
Monopsony Power in the Hospital Labor Market
May 14, 2025 by
Kevin E. Pflum & Christian Salas